You are here

Drug Forecast

Rimonabant (Acomplia): The First Cannabinoid-1 Receptor Blocker for Obesity

Carla A. Luque, PharmD, Megan J. Ehret, PharmD, and Jose A. Rey, PharmD, BCPP
PDF version: 
The authors review rimonabant (Acomplia) for the treatment of obesity.